Vascular endothelial growth factors (VEGF) as a major parameter for diagnosis and follow up of a patient with POEMS syndrome

  • Neta Goldschmidt*
  • , Ami Verber
  • , Tzahi Neuman
  • , Inna Kalikhman
  • , Vivian Barak
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

POEMS syndrome, also termed osteosclerotic myeloma, is a rare multi system disorder including polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions. Increased level of cytokines, specifically serum VEGF, seems to have a role in the disease pathogenesis. We present a patient with polyneuropathy and a lytic (not sclerotic) plasmacytoma that was diagnosed with POEMS syndrome. In this case VEGF served as a major diagnostic criterion. Following treatment, VEGF proved to be an important biological marker for therapeutic response, which preceded the clinical response. We conclude that in patients with polyneuropathy, evaluation of serum VEGF levels should be part of the initial workup to shorten time to diagnosis and improve disease management.

Original languageEnglish
Pages (from-to)348-352
Number of pages5
JournalJournal of Neurological Sciences
Volume27
Issue number3
StatePublished - 2010
Externally publishedYes

Keywords

  • POEMS
  • Polyneuropathy
  • VEGF
  • Vascular endothelial growth factor

Fingerprint

Dive into the research topics of 'Vascular endothelial growth factors (VEGF) as a major parameter for diagnosis and follow up of a patient with POEMS syndrome'. Together they form a unique fingerprint.

Cite this